From Aging/Disease to Youth/Health Economic, Scientific...
Transcript of From Aging/Disease to Youth/Health Economic, Scientific...
New York, Dec 9, 2016 No Disclosures
From Aging/Disease to Youth/Health
Economic, Scientific, Educational
The Three Upcoming Challenges
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
Interheart - PURE Inv. (S Yusuf et. al.) NEJM 2014; 371: 818
CV Risk-Factor Burden in HML I Countries
CV Case Fatality Rates in HML I Countries
PARADOX
PARADOX
LJ Laslett et. al. JACC 2012;60:S1 –
Age-Adjusted Deaths for CVD, CAD & Stroke
US 1980 to 2008 – The 50% / 50%
Projected Direct Costs of Total CVD
by Type of Cost (in Billions) - / 50%
ACC BOT’ ESWG Members (L Laslett et. al.) JACC 2015; 66 (suppl D).
Value of Primordial and Primary Prevention
for Cardiovascular Disease
A Policy Statement From the American Heart Association
Public policy, community efforts, and pharmacological
interventions are all likely to be cost-effective and often cost
saving compared with common benchmarks. The high
direct medical care and indirect costs of cardiovascular
disease—approaching $450 billion a year in 2010 and
projected to rise to over $1 trillion a year by 2030—make this
a critical medical and societal issue. Prevention of CVD will
also provide great value in developing a healthier, more
productive society.
WS Weintraub et al., Circulation 2011; 124:967
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
T Münzel et al. Eur Heart J 2015;36:1777
KE Cosselman et. al. Nat. Rev. Cardiol. 2015;12:627
Pulmonary. Oxidative Stress
Proposed Cardiovascular Side Effects
Of Noise & Air Pollution - ROS
A
B
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
1). Risk Factors of CV Disease
White Matter & Lacunar Lesions (DBD)
MA Lim et. al. Clin Geriatr Med. 2009;25:191.
JC Kovacic, V Fuster et. al. Circulation. 2011;123:1900
1B
Cerebral Microcirculation - 6 Studies
1.V Novak, I Hajjar. Nat. Rev. Cardiol. 2010; 7:686 – A’sD
2. HW Querfurth et al NEJM 2010;362:329 - Ischemia 60-90% A’sD
3. JT O’Brien et. al. Lancet. 2015;386:1698 - Autopsy
4. CARDIA (K Yaffe et al) Circ 2014;129:1560 - CV RFrs , Cognitive
5.JI Friedman et al. JACC CV Imag. 2014;7:1039 - Imaging
6. FINGER (T Ngandu et al)., Lancet 2015; 385:2255 - Intervention
Impact of Hypertension on Cognitive Function
A Scientific Statement From the AHA
Hypertension disrupts the structure and function of cerebral blood vessels, leads to ischemic damage of white matter regions critical for cognitive function, and may promote Alzheimer pathology. There is strong evidence of a deleterious influence of midlife hypertension on late-life cognitive function. Observational studies demonstrated a cumulative effect of hypertension on cerebrov. damage, but evidence from clinical trials that antihypertensive treatment improves cognition is not conclusive.
C Iadecola et al., Hypertension 2016 (In Press)
BP Lowering in Key Subgroups
-5 0Cand/HCTZ
better
Placebo
better
5
Age-years
72 (Mean=71.0)
72-75 (Mean=73.3)
>75 (Mean=78.1)
SBP-mmHg
133.0 (Mean=123.8)
133.0-140.0 (Mean=139.1)
>145.0 (Mean=156.3)
HOPE-3 Investigators (J Bosch et. al.) 2016 (AHA)
ROSUVASTATIN IN KEY SUBGROUPS
Age-years
72 (Mean=71.0)
72-75 (Mean=73.3)
>75 (Mean=78.1)
LDL-mg/dl
112 (Mean=88.7)
112-140 (Mean=125.7)
>140 (Mean=164.9)
-5 0Rosu
better
Placebo
better5
HOPE-3 Investigators (J Bosch et. al.) 2016 (AHA)
DBD & Alzheimer’s Disease
Increasing evidence suggests that many lifestyle-related factors, including diabetes, obesity, physical and mental inactivity, depression, smoking, low educational attainment, and diet have a role in dementia, and the potential for primary prevention related to such modifiable risk factors is huge but yet to be fully explored. On the basis of the Rotterdam study, it has been modelled that elimination of the seven most important modifiable risk factors would lead to a 30% reduction in dementia incidence.
P Scheltens et al., The Lancet 2016; 388:507
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
2). CV Drugs – Underuse
Risk Factors - Proportion of Participants at Goal % – 1 year
Trials L SBP DBP Hb A1C Meet Goals
BARI-2D 75 56 70 52 14 20
COURAGE 51 55 55 59 12 19
FREEDOM 55 63 53 55 12 20
Freedom, Bari-2D, Courage Investigators, JACC 2013;61:1607
PURE (S Yusuf et al.) Lancet 2011; Aug 28 - Poor Countries,7% !!!
NHANES, AHA, NHLBI-JNC-7, NHLBI-NCEP – < Adherence
P Muntner, V Fuster et al., AHJ 2011; 161: 719 – 49 seconds !!!!
CABG Versus PCI -Impact of Adherence to Medical
Therapy on Comparative Outcomes
All non-STEMI patients undergoing revascularization in an 8-hospital network were followed for up to 8 years. Among the 973 CABG and 2255 PCI patients. There was a significant benefit for antiplatelet, lipid-lowering, and -blocker therapy in both the CABG and PCI groups. Compliance with optimal medical therapy as a more powerful predictor of major adverse cardiac event-free survival than choice of therapy.Among comparable patients who adhere to optimal medical therapy, outcomes of PCI and CABG may not differ; however, among nonadherent patients, CABG affords better major adverse cardiac event-free survival.
P Kurlansky, M Mack et al., Circulation 2016; 134:1238
CV Drugs Underuse - Polypill, 2ary Prevention*
Am. H J 2011;162:811 Semin.Thor.Cardiov.Surg 2011;23:24JACC, 2014; 64:2071 JACC. 2016; 68:789 Approved in 27 Countries
* Valentín Fuster (inventor)
FOOD INTERACTION
PHARMACOKINETIC INTERACTION WITH ASPIRIN
PHARMACOKINETIC INTERACTION WITH
SYMVASTATIN
PHARMACOKINETIC INTERACTION WITH RAMIPRIL
PHARMACODYNAMIC INTERACTION WITH ASPIRIN
PHARMACODYNAMIC INTERACTION WITH
SYMVASTATIN
PHARMACODINAMIC INTERACTION WITH RAMIPRIL
BIO-EQUIVALENCE
ASA, Statin, ACE-Inhibitor
ArgentinaBrazilParaguayItalySpain
FOCUS 1 & 2
FREEDOM
AETNA-DIABETES
SECURE-EC 2016
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
3). Plaque Burden (N=12,000)
Carotid 3D-US, Coronary Calcification
PI: Valentin Fuster, Mobile Units - AHJ 2010;160:49
H Sillesen, P Muntendam, E Falk, V Fuster et.al JACC Imag. 2012;7:681.
U Baber, R Mehran, V Fuster, et al. J. Am. Coll. Card. 2015; 65: 1065
Upcoming 8 Year Follow up
3a).Three Year All-Cause MACE Rates (N=216)
by Carotid and Coronary Atherosclerosis
Reclassification: CAC 24% - cPB 18%
3b). Distribution Of The Systemic Extent
Of Subclinical Atherosclerosis
PESA (L Fernandez-Friera, A Fernandez-Ortiz, V Fuster et.al) Circulation 2015;131:2104
3c). Framingham, When Positive Coronary Artery
Calcification Score and Ultrasound are Added
Variables included in the prediction model Variables included in the prediction model
0.665 0.689 0.706 0.719 0.743 0.778 0.810 0.827
AWHS - M Lacaustra, V Fuster et al. JACC 2016; 67: 1263
Tarkin JM, Dweck M, Fayad ZA et al. Circ Research 2016 (in Press)
CT / PET–Carotid and CxCA Plaques / Inflammation
Culprit Plaque Identified In Acute MI
Coronary Angiogram Fused 18F-NaF PET CT
Joshi N, Dweck M, Vesey A, Rudd JHF, Newby DE et al Lancet 2014
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
4a). AMPATH Centers In Kenya
BP Control / Non MD / High Technology
R Vedanthan, V Fuster, NHLBI / Kenya Model (2012-2016)
86
69
96
104
127
70
86
N=552
4b). The Seven Community Study
Spain - E. Gomez, V Fuster et al JACC 2016; 67:476
Cardona Integral – “Fifty-fifty” - 2014
Global Demonstration Project – GHP – 2013
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
VILLAGE
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
JN Giedd. Scientific American 2015;312:32
5). Child’s Brain Development
Less Networking Brings Atention
3B
GENERAL
PUBLIC
3-5CHILDREN 6-8 9-14
EDUCATIVE GOAL: HEALTHY HABITS FOR CHILDREN BETWEEN 3 & 5 YRS
COLOMBIA – CHILDREN’S PROGRAM
CHILDREN’S – BOGOTA, SPAIN, NEW YORK – N = 50,000
The Amer J of Med 2013;126:1122 - J. Amer. Coll. Card. 2015;65:1065J. Amer. Coll. Card. 2016 (In Press)
Primordial
Secondary
Primary
50/50
Translation Studies Towards
Promoting Healthy Aging
5) SHE
HARLEM
VILLAGE
MEXICO
3)1)
2)
4) IIIP
HRP
Surg.Interv.
PESA
AWHS
TANSNIP
BARRIERS TO IMPLEMENTATION OF A HEALTH
PROMOTION PROGRAM IN HARLEM, NY
THE FAMILIA STUDYAn AHA Strategically Focused Research Network Study
Sameer Bansilal, MD, MS, Rajesh Vedanthan, MD, MPH, Risa Jaslow, MS, RDN,
Martha Hadley, PhD, Amy Siskind, PhD, Carmina Marcial, MA, Ana Victoria Soto,
MD, Claire Kofler, BS, Zahi A Fayad, PhD, Valentin Fuster, MD,PhD
O
Start
Start
Children
3 Groups
Caregivers
3 Groups
P
P
P
P
P
P
Teachers
O
I
I
I
O
O
O
O O
O
O
O
O
O
KAH-BEA
Mol. Genomics KAH-BEAS-KAH-BEA
BEWAT
Point of Care.
3D-US
Mol. Genomics
O
IP
II II
O
IP
Contr./Interv.
S-BEWAT
Point of Care
BEWAT
Point of Care
3D-US
Mol. Genomics
1st
Yr 2nd
Yr 3rd
Yr 4th
Yr
Intervention.
Intervention
Control
IIIP
PPPI
KAH-BEA = Knowledge, Attitude, Habit, -BMI, Exercise, Alimentation ; FUSTER-BEWAT = BP, Exercise, Weight, Alimentation, Tobacco; S=Sustained
(1)
(2)
(3)
(3)
(1)
(2)
IT & Lifestyle: A Systematic Evaluation of Internet
and Mobile Interventions for Improving Diet, Physical
Activity, Obesity, Tobacco, & Alcohol Use
224 relevant reports were identified. Internet
interventions improved diet (N=20 studies), physical
activity (N=33), adiposity (N=35), tobacco (N=22),
and excess alcohol (N=47). Internet and mobile
interventions improve important lifestyle behaviors
up to 1 year. This systematic review supports the
need for long-term interventions to evaluate
sustainability.
A Afshin et al., J Am Heart Assoc 2016; 5:e003058
46Confidential, for Internal and Investigator use only
Lanzamiento de la versión internacional THE CIRCLE OF HEALTH
Actividades previstas
Interactive “Circle of Health” - App
www.thecircleofhealth.org
EDUCATION (7)
CARDONA - MEXICO
HARLEM
SPAIN
GRENADA
KENYA
SPAIN
BOGOTA
Co
ntin
uity
Village (1)
Family (1)
Adults (2)
Children (2)
CONCEPTS, SCIENTIFIC STUDIES , NPOs
From Aging/Disease to Youth/Health
B
B
B
Prom.
Health
Subcl.
Disease
Stable
Disease
Window
Young
Our Future
Behav.
Change
Simplicity
Adherence
25 50 100
25 50 100
A
Present
Too Late Earlier
1. Economic
A
A0
2. Scientific
V Fuster, JACC 2015; 66: 1627
Environment
Health Policy
3. Educational
0